JGC
TNDM icon

J. Goldman & Co’s Tandem Diabetes Care TNDM Stock Holding History

J. Goldman & Co’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-43,098
Closed -$4.26M – 385
2020
Q2 		$4.26M Buy
43,098
+11,388
+36% +$909K 0.26% 108
2020
Q1 		$2.04M Sell
31,710
-120,767
-79% -$8.46M 0.25% 102
2019
Q4 		$9.09M Buy
+152,477
New +$9.4M 0.65% 46

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

J. Goldman & Co's TNDM Position: Q3 2020 in Review

J. Goldman & Co sold out of Tandem Diabetes Care (TNDM) in Q3 2020, closing a stake of 43,098 shares — an estimated $4.26M sold.

J. Goldman & Co first reported a position in TNDM in Q4 2019 and held it in 3 quarters. The position peaked at $9.09M in Q4 2019. 321 funds tracked by Wall St. Rank hold TNDM as of Q3 2020.

  • J. Goldman & Co reported no remaining Tandem Diabetes Care position as of Q3 2020 after selling out during the quarter.
  • J. Goldman & Co sold 43,098 Tandem Diabetes Care shares in Q3 2020, an estimated $4.26M.
  • J. Goldman & Co first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 3 quarters.
  • J. Goldman & Co's Tandem Diabetes Care position peaked at $9.09M in Q4 2019.
  • 321 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2020.

Based on J. Goldman & Co's 13F filing for Q3 2020, filed 16 Nov 2020.